Fingolimod News and Research

RSS
Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Researchers develop fast diagnostic tool that shows MS patients in relapse

Researchers develop fast diagnostic tool that shows MS patients in relapse

Researchers use structural biology techniques to understand how lipids bind proteins

Researchers use structural biology techniques to understand how lipids bind proteins

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

UA pharmacology professors aim to avoid opioid analgesic tolerance

UA pharmacology professors aim to avoid opioid analgesic tolerance

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

New combination therapy for cancer cells could soon be a reality

New combination therapy for cancer cells could soon be a reality

FDA approves new drug to treat MS in pediatric patients

FDA approves new drug to treat MS in pediatric patients

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Established therapeutic drugs may be effective against childhood dementia

Established therapeutic drugs may be effective against childhood dementia

New treatment may hold promise for progressive form of multiple sclerosis, study suggests

New treatment may hold promise for progressive form of multiple sclerosis, study suggests

IUPUI scientists develop new synthetic method to shorten drug discovery and development process

IUPUI scientists develop new synthetic method to shorten drug discovery and development process

S1P1R variation may cause differential patient responses to fingolimod treatment

S1P1R variation may cause differential patient responses to fingolimod treatment

PET imaging can help identify autoimmune inflammation in MS

PET imaging can help identify autoimmune inflammation in MS

Real risk of rebound syndrome following fingolimod cessation for MS

Real risk of rebound syndrome following fingolimod cessation for MS

Rituximab outperforms fingolimod after natalizumab switch

Rituximab outperforms fingolimod after natalizumab switch

Rituximab drug more effective than fingolimod for patients with highly active multiple sclerosis

Rituximab drug more effective than fingolimod for patients with highly active multiple sclerosis

Added benefit of multiple sclerosis drug fingolimod not proven, says IQWiG

Added benefit of multiple sclerosis drug fingolimod not proven, says IQWiG

Promising phase II results for ozanimod in MS

Promising phase II results for ozanimod in MS